ARCA BIOPHARMA INC's ticker is ABIO and the CUSIP is 00211Y506. A total of 24 filers reported holding ARCA BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 0.00 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Western Standard LLC | 1,174,270 | $2,360,283 | 2.13% |
| BML Capital Management, LLC | 706,930 | $1,420,929 | 1.30% |
| Newtyn Management, LLC | 300,000 | $603,000 | 0.15% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 46,948 | $94,365 | 0.00% |
| OSAIC HOLDINGS, INC. | 55 | $110 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 42,514 | $85,453 | 0.00% |
| Parallel Advisors, LLC | 244 | $490 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 31 | $62 | 0.00% |
| WELLS FARGO & COMPANY/MN | 75 | $151 | 0.00% |
| NORTHERN TRUST CORP | 20,982 | $42,174 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 142,349 | $286,163 | 0.00% |
| STATE STREET CORP | 71,137 | $142,985 | 0.00% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 14,988 | $30,126 | 0.00% |
| BlackRock Inc. | 231,959 | $466,237 | 0.00% |
| Citadel Advisors | 10,700 | $21,507 | 0.00% |
| Citadel Advisors | 100 | $201 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 28,600 | $57,486 | 0.00% |
| Qube Research & Technologies Ltd | 50 | $101 | 0.00% |
| Tower Research Capital LLC (TRC) | 3,691 | $7,419 | 0.00% |
External links
This page lists ARCA BIOPHARMA INC's shareholders in Q3 2023. To view ARCA BIOPHARMA INC's shareholder history, click here.